tm logo
ITULATEK
Live/Registered
REGISTERED

on 04 Aug 2020

Last Applicant/ Owned by

Bøge Allé 6-8

Hørsholm

DK

DK-2970

Serial Number

87886775 filed on 20th Apr 2018

Registration Number

6115768 registered on 04th Aug 2020

in the Principal Register

Correspondent Address

Monica Riva Talley

STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C

1100 NEW YORK AVENUE, N.W.

WASHINGTON, DC 20005

Filing Basis

1. intent to use

Disclaimer

NO DATA

ITULATEK

Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis and respiratory allergic diseases, and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinocRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis and respiratory allergic diseases, and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, for the treatment, monitoring and diagnosing of allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, diagnostic reagents and diagnostic testing materials being medical diagnostic test strips, diagnostic test patch for application to the skin for determining allergies, medical diagnostic test media in the form of test strips, all for medical use in diagnosing, preventing and treating allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases

Class [042]
Computer & Software Services & Scientific Services


Medical and pharmacological research services in relation to allergies, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; conducting clinical trials for others

Class [044]
Medical, Beauty & Agricultural Services


Medical consulting services, namely, counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases; providing patient support, namely, providing medical and health care information, all relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases, through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums and electronically or digitally through the Internet; providing health and medical information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, rhinoconjunctivitis, and respiratory allergic diseases through printed publications, pamphlets, brochures, flyers, through telephone, through meetings, conferences, symposiums, and electronically or digitally through the Internet

Mark Details


Serial Number

No 87886775

Mark Type

No Service Mark

Attorney Docket Number

No 3985.0060000

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
04th Aug 2020REGISTERED-PRINCIPAL REGISTER
19th May 2020PUBLISHED FOR OPPOSITION
19th May 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29th Apr 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10th Apr 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10th Apr 2020EXAMINERS AMENDMENT E-MAILED
10th Apr 2020APPROVED FOR PUB - PRINCIPAL REGISTER
10th Apr 2020EXAMINER'S AMENDMENT ENTERED
10th Apr 2020EXAMINERS AMENDMENT -WRITTEN
26th Mar 2020TEAS/EMAIL CORRESPONDENCE ENTERED